Gene therapy mini-series: Enhancing the delivery of gene therapy through specific care models

— Pfizer, ARM, Dolon

While gene therapies offer the potentially groundbreaking opportunity to improve outcomes for individuals with rare and severe diseases, their adoption introduces distinct challenges for health systems that are currently tailored for more conventional medicines. As such, there is a significant opportunity to improve care delivery and increase patient access to current and future gene therapies.

In this four part series, explore the opportunities and best practices that relate to the following topics:

• Promoting multi-stakeholder education to support access to gene therapy
• Facilitating effective health technology assessment for gene therapy
• Novel payment models to facilitate patient access to gene therapy